Addicts treated with monoclonal antibodies

U.S. researchers have technology for the production of antibodies that selectively patented to amphetamine derivatives. Scientists say they have created the compounds to be effective in the prevention and treatment of drug dependence. In recent years, amphetamine and its derivatives - are the number one problem of the U.S. drug treatment - methamphetamine and ecstasy. Abuse of these drugs leads to serious disorders of the central nervous system and cardiovascular diseases. Effective treatments for amphetamine addiction at present. The staff of the Center for Drug and Alcohol, University of Arkansas for various types of monoclonal antibodies that selectively synthesized to bind to molecules of amphetamine, methamphetamine and ecstasy, have to contribute to their rapid clearance of experiments addicted mice and rats showed that injection of monoclonal antibodies, the concentration of the active substance in the blood of substances obtained rodents at a minimum. In addition, patients had to receive the experimental treatment of animals there a decrease drug use, despite the presence of a permanent access. When they realize they have created antibodies. Hardly interact with isomers of amphetamine, which are used in some public drug This denies receiving "anti-drug vaccine" addicts to override their actions with the available drugs.